Wada N, Abe N, Miyauchi K, Ishikawa M, et al. Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement. Int Urol Nephrol 2022;54:31-36.
PMID: 34767140